Series B · Consumer

All Home raises ₹200 crore in equity and debt

Bessemer Venture Partners leads the equity backing, while Stride Ventures provides the debt component.

All Home announced ₹200 crore in financing on June 26, 2026, combining equity and debt. Existing backer Bessemer Venture Partners and unnamed family offices led the equity side; Stride Ventures supplied the debt.

Counsel Touchstone Partners identified the financing as a Series B. The company was valued at ₹2,000 crore in the transaction, double the valuation reported after its June 2025 financing.

All Home said its first full financial year, 2025–26, generated about ₹180 crore in revenue. Founded by PharmEasy’s co-founders, the business invests in specialist home improvement brands and supports their growth with manufacturing, technology and distribution.

Use of funds

Strengthen technology stack

Expand experience centres

Develop manufacturing facilities

Funding history

Series B · This round₹2B
Initial financing~$20M

Sources

  1. Pharmeasy founders’ new venture All Home raises Rs 200 crore; valuation doubleseconomictimes.indiatimes.com · Jun 26, 2026
  2. Touchstone advises AllHome SeriesBbarandbench.com · Jul 1, 2026